Soralimixin

N/A

Report date: 2025/12/16 17:18:11
NME

Base Information

Drug NameSoralimixin
Drug Alias NameQPX-9003BRII-693
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Lipopeptide antibiotics
Mechanisms of ActionCell membrane function inhibitors
TargetsNot applicable
Therapy Area/IndicationsPseudomonas InfectionsAcinetobacter InfectionsGram-Negative Bacterial Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMonash University
China Registration ClassN/A

Develop Information

Active CompaniesQpex Biopharma IncBrii Biosciences LtdBrii Biosciences Inc +[4] 
Inactive CompaniesN/A
Active IndicationsPseudomonas InfectionsAcinetobacter InfectionsGram-Negative Bacterial Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A